Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 16 von 1036
European review for medical and pharmacological sciences, 2021-01, Vol.25 (1), p.541
2021
Volltextzugriff (PDF)

Details

Autor(en) / Beteiligte
Titel
Remdesivir as a broad-spectrum antiviral drug against COVID-19
Ist Teil von
  • European review for medical and pharmacological sciences, 2021-01, Vol.25 (1), p.541
Ort / Verlag
Italy
Erscheinungsjahr
2021
Quelle
MEDLINE
Beschreibungen/Notizen
  • List the clinical data of the role of remdesivir in COVID-19, and try to make an objective evaluation and analyze its feasibility. The keywords of "remdesivir", "COVID-19" and "SARS-CoV-2" were systematically searched in PubMed and Web of Science. After removing the repetitions, we summarize articles, letters, and comments on remdesivir in the treatment of COVID-19. In this review, we summarize clinical case of using remdesivir in the treatment of COVID-19, analyzed the final treatment results, and judged whether the drug was effective for the treatment of COVID-19. Also, attention was paid to the side effects of the drug. According to the clinical results, it was found that remdesivir was effective in the treatment of COVID-19. The drug has side effects, but the symptoms were mild and disappeared immediately after discontinuation of medication.

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX